# Evaluation of the MP Diagnostics HTLV Blot 2.4

> **NCT01467024** · — · UNKNOWN · sponsor: **MP Biomedicals, LLC** · enrollment: 600 (estimated)

## Conditions studied

- HTLV-I Infections
- HTLV-II Infections
- Human T-lymphotropic Virus 1
- Human T-lymphotropic Virus 2
- HTLV I Associated T Cell Leukemia Lymphoma
- HTLV I Associated Myelopathies

## Interventions

- **OTHER:** CDPHL Algorithm

## Key facts

- **NCT ID:** NCT01467024
- **Lead sponsor:** MP Biomedicals, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-11
- **Primary completion:** 2012-01
- **Final completion:** 2012-06
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2011-11-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01467024

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01467024, "Evaluation of the MP Diagnostics HTLV Blot 2.4". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01467024. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*